Rozerem Ads Innovatively Ineffectual Posted: October 26, 2006 At yesterday's "DTC in the New Era" conference organized by DTC Perspectives, Inc., Dale Taylor, President & CEO of AbelsonTaylor, Inc., which is the agency responsible for the Rozerem ads, made several revealing comments about the Rozerem DTC ads even though he coyly said that he was "not going to talk about the Rozerem campaign." He confirmed what most of us already suspected: the ads were created to be "different," "to create buzz," and to make sure there was "a lot of talk about" the ads. Note that he didn't say the goal was to generate a lot of talk about Rozerem -- just about the ads. Mission Accomplished, Dale! Unfortunately, all the benefit goes to AbelsonTaylor, not to the Rozerem brand nor to AbelsonTaylor's client, which is Takeda Pharmaceuticals. Read more about why I say this in today's post to Pharma Marketing Blog. For more posts in related topic areas, see: Buzz/Public Relations/Image DTC Advertising Sleep Aid Drugs If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe. Enter your Email Address | Return to Pharma Marketing Blog Topics |

Supplement Sale! Collections of the Best Articles from Pharma Marketing News Only $12.95 Each! Click here to order online NOW. Relationship Marketing ePharma Marketing Physician Education Sales Force Effectiveness eDetailing Only $12.95 Each! Click here to order online NOW.